Editorial
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 100546
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.100546
Figure 1
Figure 1 Protein tyrosine phosphatase nonreceptor 2 gene mutations and gene expressions. A: Tumors with protein tyrosine phosphatase nonreceptor 2 (PTPN2) mutations according to The Cancer Genome Atlas. Gastrointestinal (GI) cancers are marked with arrows; B: Distribution of PTPN2 gene expression in GI cancers and adjacent tissues according to GEPIA data. ESCA: Esophageal cancers; STAD: Stomach adenocarcinomas; COAD: Colon adenocarcinoma; LIHC: Liver hepatocellular carcinoma; Chol: Cholangiocarcinoma; PAAD: Pancreatic Adenocarcinoma.
Figure 2
Figure 2 Plots of gene copy number changes detected in gastrointestinal cancers among 10953 patients included in the The Cancer Genome Atlas PanCancer Atlas Studies investigating protein tyrosine phosphatase nonreceptor 2. A: Esophageal cancer; B: Gastric cancer; C: Colorectal cancer; D: Liver hepatocellular carcinoma; E: Pancreatic adenocarcinoma.